Fish vaccination (plus biosecurity and probiotics) instead of prophylactic/metaphylactic antibiotics in finfish aquaculture

Replaces: routine antibiotics in medicated fish feed · Species: farmed fish · Evidence: high

The chemical problem#

Medicated feed releases a large part of the antibiotic directly into water and sediment (uneaten feed and faeces), which selects resistant bacteria in the environment. Large amounts of antibiotics, often not tracked, are used in aquaculture in Asia and Latin America (for example, heavy use in Chilean salmon farming against Piscirickettsia salmonis). Residues of banned drugs (chloramphenicol, nitrofurans) are regularly found in imported fish and shrimp by EU border controls.

Product overview#

Norway is the reference case. In 1987 Norwegian salmon farming used about 50 tonnes of antibiotics for about 50,000 t of fish. After vaccines against cold-water vibriosis, furunculosis (Aeromonas salmonicida) and later other diseases were introduced, and combined with biosecurity, antibiotic use fell to about 1 tonne or less per year while production rose to more than 1 million tonnes, a reduction of more than 99 % per kg of fish.

The program has four parts:

1. Vaccination: injectable, oil-adjuvanted multivalent vaccines (salmonids, sea bass), immersion (dip) vaccines for fry, and oral booster vaccines. Autogenous vaccines are used for farm-specific strains (e.g. tilapia Streptococcus).
2. Biosecurity: fallowing, single year-class sites, disinfected well-boats, and health certification of smolts.
3. Probiotics and functional feeds (Bacillus, lactic acid bacteria, β-glucans, nucleotides): these support the immune system.
4. Genetics: selective breeding for disease resistance (e.g. IPN-resistant QTL salmon, which nearly eliminated IPN outbreaks in Norway).

Active ingredient / Composition#

Inactivated bacterins (Vibrio anguillarum, V. salmonicida, A. salmonicida, Moritella viscosa, Yersinia ruckeri, Streptococcus agalactiae/iniae, Lactococcus garvieae), viral antigens (IPNV, SAV and others), in mineral-oil or other adjuvants; immersion and oral formulations.

Key facts#

Advantages#

• A proven industrial-scale reduction in antibiotics (Norway, Faroe Islands, Scotland).
• Lower mortality and better feed conversion, which means lower cost per kg.
• Residue-free fish give export-market access.

Mode of action#

Specific antibodies (IgM) and cell-mediated immunity protect against the targeted pathogens. Oil adjuvants give long-lasting (months-long) protection.

Application#

Limitations#

• Not all diseases have effective vaccines (e.g. Piscirickettsia vaccines are only partly effective; many viral diseases).
• Injection is labour-intensive, and oil adjuvants can cause side effects (adhesions).
• Some small-scale pond systems cannot vaccinate individually; for them, biosecurity and water quality matter most.

Evidence of displacement — D3: proven displacement at scale#

Assessment (hand-reviewed): National: Norwegian salmon antibiotic use fell from ~50,000 kg (1987) to 1,000–2,000 kg (1997) after vaccination.

Verified figures (the number is in the quoted sentence and the sentence is on the source page):

• displacement — In the Norwegian salmon farming industry, the introduction of preventive vaccination strategies led to a dramatic reduction in annual antibiotic use from approximately 50,000 kg in 1987 to less than 1,000–2,000 kg by 1997. (Norway, 1987–1997; peer-reviewed: onlinelibrary.wiley.com)

Suppliers — real products and services (from the vendor index)#

Honest finding: the vendor index has no fish-vaccine maker besides Barramundi Group’s in-house platform; the others make autogenous animal vaccines. This is recorded as a supplier gap — the companies below are the closest capabilities.

Companies below are active vendors in the vendor index whose own card (profile / official website) shows this product or service — matched 2026-09-28 by keyword and checked by hand against the card text. Being listed is not an endorsement; open each card for evidence, contacts and status.

Update 2026-10-05: the new Europe dataset supplies this product — rows marked Europe below. For the other regions the gap noted above still stands unless a row says otherwise.

Government funding signals#

Public grants for a specific technology are a leading indicator: governments fund what regulators want to replace and what is close to practical adoption. Searched on 2026-09-27 in: EU CORDIS (FP7, Horizon 2020, Horizon Europe), US federal awards (USAspending: USDA NIFA/ARS/APHIS/Forest Service, EPA, DOE, NOAA, USAID; plus NSF and NIH), UK UKRI Gateway to Research, Australian Research Council. Each grant below was reviewed by hand for relevance. China, Brazil and India are covered in the subsection below (publication-acknowledged grants). Not covered: Russia (RSF, FASIE — not reachable from the research environment) and national agencies outside these databases. Amounts are the funder’s contribution as recorded (US NIH/UKRI: per award or fiscal year).

Signal: Strong. 4 relevant grant(s) · about €14.9M in total · jurisdictions: EU, UK, USA.

China, Brazil, India — national research grants acknowledged in publications#

Chinese, Brazilian and Indian funders have no open grant databases reachable here, so this measures scientific papers published since 2015 that acknowledge national government grants, taken from the grant numbers publishers deposit with Crossref. Only papers whose title contains this article’s key terms are counted (a conservative lower bound; “100+” = search window full). It shows research-funding intensity, not budgets. Funders: China — NSFC, National Key R&D Program, China Agriculture Research System; Brazil — CNPq, CAPES, FAPESP, Embrapa, FAPEMIG; India — DBT, DST, ICAR, SERB, CSIR, BIRAC. Rating per country: Strong ≥50 papers · Moderate 10–49 · Weak 1–9.

Scientific evidence#

• Midtlyng PJ, Grave K, Horsberg TE (2011). What has been done to minimize the use of antibacterial and antiparasitic drugs in Norwegian aquaculture? Aquaculture Research 42 (Suppl. 1): 28–34.
• Gudding R, Van Muiswinkel WB (2013). A history of fish vaccination: science-based disease prevention in aquaculture. Fish & Shellfish Immunology 35: 1683–1688.
• Cabello FC (2006). Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environmental Microbiology 8: 1137–1144.
• Defoirdt T, Sorgeloos P, Bossier P (2011). Alternatives to antibiotics for the control of bacterial disease in aquaculture. Current Opinion in Microbiology 14: 251–258.
• Moen T, Baranski M, Sonesson AK, Kjøglum S (2009). Confirmation and fine-mapping of a major QTL for resistance to infectious pancreatic necrosis in Atlantic salmon (Salmo salar): population-level associations between markers and trait. BMC Genomics 10: 368.

Bioeconomy value#

Biological vaccines, genetics and probiotics replace antibiotics in the “blue bioeconomy”. The result is cleaner water, residue-free seafood, and less resistance spread through the aquatic environment.